期刊文献+

40岁以上成人接种乙肝疫苗免疫原性及影响因素分析 被引量:2

Immunogenicity and influencing factors of hepatitis B vaccine inadults over 40 years old
原文传递
导出
摘要 目的 了解≥40岁成人乙肝疫苗接种后免疫原性及影响因素。方法 2021年1月1日—2022年1月选取北京市通州区马驹桥和甘棠社区无乙肝疫苗接种史,乙肝五项血清标志物指标均阴性的≥40岁人群,随机分为0-1-6月和0-1-2月免疫程序接种HepB。全程免疫后1个月采用化学发光微粒子免疫检测技术进行乙型肝炎表面抗体(抗-HBs)的定量检测,采用χ2检验和t检验,单因素及多因素logistic回归、单因素及多因素线性回归分析抗-HBs阳性率和浓度及影响因素。结果 0-1-6和0-1-2两种免疫程序阳转率分别为79.87%和80.50%,多因素分析显示,性别(OR=2.39,P<0.05)是抗-HBs阳转率的影响因素,免疫程序、性别、年龄、肥胖与抗-HBs浓度有关。结论 ≥40岁成人0-1-6、0-1-2免疫程序接种HepB均可产生良好的免疫应答。免疫程序、性别、年龄、肥胖可影响抗体水平的产生。 Objective To understand the immunogenicity of hepatitis B vaccine in adults over 40 years old,and to discuss its influencing factors.Methods Adults over 40 years old with no history of hepatitis B vaccination and negative serum biomarkers of HepB were recruited and randomly divided into two groups.Subjects were given 3 doses of HepB vaccine at 0,1 and 6 months(group 1)or at 0,1 and 2 months(group 2).One month after the last dosage,the anti-hepB surface antigen-antibody(anti-HBs)in serum samples was quantified using chemiluminescent microparticle immunoassay.Chi-square test and t-test,univariate and multivariate logistic regression as well as single and multiple linear regression were used to analyze and compare the positive rate and serum levels of anti-HBs and its influencing factors.Results The seropositivity rate was 79.87%in group 1 and 80.50%in group 2.Multivariate regression analysis showed that gender(OR=2.36,P<0.05)was the major influencing factor for anti-HBs seroconversion rate,while sex,age,obesity and dosing schedule were factors related to anti-HBs concentration.Conclusions Both 0-1-6 and 0-1-2 dosing schedules for HepB vaccination can trigger decent immune response in adults over 40 years old.Dosing schedule,sex,age,obesity are major factors affecting the antibody level in serum.
作者 赵春艳 孙远洁 石晶 张建明 张国峰 吴疆 高培 ZHAO Chunyan;SUN Yuanjie;SHI Jing;ZHANG Jianming;ZHANG Guofeng;WU Jiang;GAO Pei(Institute for Immunization and Prevention,Tongzhou District Center for Disease Control and Prevention,Beijing 101100,China)
出处 《中国预防医学杂志》 CAS CSCD 北大核心 2023年第7期693-697,共5页 Chinese Preventive Medicine
基金 首都卫生发展科研专项(首发2018-1-3011) 北京市卫生系统高层次卫生技术人才队伍建设专项(学科骨干-01-043)。
关键词 成人 乙型肝炎 乙型肝炎疫苗 免疫效果 Adults Hepatitis B Hepatitis B vaccine Immune effect
  • 相关文献

参考文献19

二级参考文献188

共引文献298

同被引文献34

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部